Application of an unsupervised multi-characteristic framework for intermediate-high risk prostate cancer localization using diffusion-weighted MRI-Reference-Cited by-同舟云学术

Application of an unsupervised multi-characteristic framework for intermediate-high risk prostate cancer localization using diffusion-weighted MRI

Published:2016-11 Issue:9 Volume:34 Page:1227-1234
ISSN:0730-725X
Container-title:Magnetic Resonance Imaging
language:en
Short-container-title:Magnetic Resonance Imaging

Author:

Freidlin Raisa Z.,Agarwal Harsh K.,Sankineni Sandeep,Brown Anna M.,Mertan Francesca,Bernardo Marcelino,Daar Dagane,Merino Maria,Citrin Deborah,Wood Bradford J.,Pinto Peter A.,Choyke Peter L.,Turkbey Baris

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Biomedical Engineering,Biophysics

Reference36 articles.

1. Cancer statistics, 2014;Siegel;CA Cancer J Clin,2014

2. Multiparametric MRI in biopsy guidance for prostate cancer: fusion-guided;Rothwax;Biomed Res Int,2014

3. Dynamic contrast-enhanced MRI and MR diffusion imaging to distinguish between glandular and stromal prostatic tissues;Noworolski;Magn Reson Imaging,2008

4. Dynamic contrast-enhanced MRI of prostate cancer at 3T: a study of pharmacokinetic parameters;Ocak;AJR Am J Roentgenol,2007

5. Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging;Oto;Radiology,2010

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mutually communicated model based on multi‐parametric MRI for automated segmentation and classification of prostate cancer;Medical Physics;2023-03-16

2. A New Framework for Precise Identification of Prostatic Adenocarcinoma;Sensors;2022-02-26

3. Artificial intelligence and imaging biomarkers for prostate radiation therapy during and after treatment;Journal of Medical Imaging and Radiation Oncology;2021-05-31

4. Diffusional kurtosis imaging in evaluation of microstructural changes of spinal cord in cervical spondylotic myelopathy feasibility study;Medicine;2020-11-20